Dominick & Dominick’s Novartis NVS Stock Holding History

Dominick & Dominick’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$2.73M	Hold	32,877	–	–	1.39%	15
2014 Q3	$2.77M	Sell	32,877 -5,525	-14%	-$447K	1.33%	18
2014 Q2	$3.12M	Sell	38,402 -2,176	-5%	-$171K	1.52%	16
2014 Q1	$3.09M	Buy	40,578 +5,469	+16%	+$399K	1.51%	15
2013 Q4	$2.53M	Sell	35,109 -447	-1%	-$31.1K	1.21%	17
2013 Q3	$2.44M	Sell	35,556 -233	-0.7%	-$15.4K	1.36%	14
2013 Q2	$2.27M	Buy	+35,789	New	+$2.33M	1.32%	14

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Dominick & Dominick's NVS Position: Q4 2014 in Review

Dominick & Dominick held its Novartis (NVS) position steady in Q4 2014 at 32,877 shares worth $2.73M. The position accounts for 1.39% of the portfolio, ranked #15.

Dominick & Dominick first reported a position in NVS in Q2 2013 and has held it in 7 quarters since. The position peaked at $3.12M in Q2 2014. 918 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

Dominick & Dominick held 32,877 shares of Novartis worth $2.73M as of Q4 2014.
Dominick & Dominick left its Novartis share count unchanged in Q4 2014.
Novartis made up 1.39% of Dominick & Dominick's portfolio in Q4 2014, its #15 holding.
Dominick & Dominick first reported a position in Novartis in Q2 2013 and has held it in 7 quarters since.
Dominick & Dominick's Novartis position peaked at $3.12M in Q2 2014.
918 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on Dominick & Dominick's 13F filing for Q4 2014, filed 22 Jan 2015.